These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27689405)

  • 21. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
    Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
    Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
    Kopiński P
    Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune system alterations in lung cancer patients.
    Mazzoccoli G; Grilli M; Carughi S; Puzzolante F; De Cata A; La Viola M; Giuliani A; Urbano N; Tarquini R; Perfetto F
    Int J Immunopathol Pharmacol; 2003; 16(2):167-74. PubMed ID: 12797908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circulating lymphocyte subsets in patients with lung cancer and their prognostic value].
    Luo J; Ling Z; Mao W
    Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):669-73. PubMed ID: 21859548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma.
    Platonova S; Cherfils-Vicini J; Damotte D; Crozet L; Vieillard V; Validire P; André P; Dieu-Nosjean MC; Alifano M; Régnard JF; Fridman WH; Sautès-Fridman C; Cremer I
    Cancer Res; 2011 Aug; 71(16):5412-22. PubMed ID: 21708957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.
    Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F
    J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients.
    Nakamura H; Kawasaki N; Hagiwara M; Saito M; Konaka C; Kato H
    Lung Cancer; 2000 May; 28(2):139-45. PubMed ID: 10717331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local CD4+, CD8+ and CD56+ reactions to lung cancer in regard to pathohistological type and clinical stage.
    Jusufovic E; Iljazovic E; Kosnik M; Keser D; Korosec P; Zukic E; Prnjavorac B; Sejdinović R; Ajanović E
    Med Glas (Zenica); 2011 Feb; 8(1):101-8. PubMed ID: 21263406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Wuye Decoction on lymphocyte phenotype in patients with non-small cell lung cancer.
    Zheng SL; Yang QS; Ma XH
    Chin J Integr Med; 2006 Jun; 12(2):118-21. PubMed ID: 16800990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral leukocytes with HLA-DR+/CD8- phenotype are associated with prognosis in patients with lung cancer.
    Nakamura H; Saji H; Aute I; Kawasaki N; Hosaka M; Ogata A; Saijo T; Kato H
    Anticancer Res; 2003; 23(5b):4149-52. PubMed ID: 14666616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
    Rüttinger D; van den Engel NK; Winter H; Schlemmer M; Pohla H; Grützner S; Wagner B; Schendel DJ; Fox BA; Jauch KW; Hatz RA
    J Transl Med; 2007 Sep; 5():43. PubMed ID: 17868452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.
    Suárez GM; Añé-Kourí AL; González A; Lorenzo-Luaces P; Neninger E; Salomón EE; Cordero L; Catalá M; Ledón N; Pereira K; Sánchez MG; García B; Crombet T; Mazorra Z; Saavedra D; Lage A
    Cancer Immunol Immunother; 2021 Jun; 70(6):1735-1743. PubMed ID: 33388995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.
    Bruno A; Focaccetti C; Pagani A; Imperatori AS; Spagnoletti M; Rotolo N; Cantelmo AR; Franzi F; Capella C; Ferlazzo G; Mortara L; Albini A; Noonan DM
    Neoplasia; 2013 Feb; 15(2):133-42. PubMed ID: 23441128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.